Brief: Guardant Health Q1 Adjusted EPS USD -0.45 Vs. IBES Estimate USD -0.76
07/05/2026 21:05
May 07 (Reuters) - Guardant Health Q1 revenue USD 301.7 million vs. IBES estimate USD 279.2 million. Q1 adjusted net income USD -58.7 million vs. IBES estimate USD -94.9 million Q1 EPS USD -0.85 Q1 adjusted EBITDA USD -58.9 million vs. IBES estimate USD -47.7 million outlook FY revenue USD 1,300-1,320 million vs. IBES estimate USD 1,271 million
Recent news on Guardant Health
See all newsBrief: Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US Health Secretary Kennedy Jr. adds eight new members to key health committee (updated)
Brief: US FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation
Brief: Guardant Health To Appeal Federal District Court Judgment